Skip to content
Screener

EyePoint, Inc. EYPT Total Current Assets

Total Current Assets at other companies

Merck & Co. logo
Merck & Co.MRK
$36.68B-1.0%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$18.45B+9.4%
Ocular Therapeutix logo
Ocular TherapeutixOCUL
$706M+82.1%
Kodiak Sciences Inc logo
Kodiak Sciences IncKOD
$175.26M+22.8%
Regenxbio logo
RegenxbioRGNX
$236.16M-36.8%
4D Molecular Therapeutics logo
4D Molecular TherapeuticsFDMT
$405.36M+21.9%

Other financials

Income statement

See full
Revenue$507.0K-90.5%
Gross profit$9.8M-30.1%
Operating income-$97.4M-56.5%
Net income-$94.5M-59.0%
EPS (diluted)-$1.09-28.2%

Balance sheet

See full
Cash & equivalents$110.5M+55.3%
Total debt$22.4M-5.7%
Total equity$166.4M-32.4%
Total assets$228.2M-24.2%

Cash flow

See full
Operating cash flow-$62.3M+0.4%
CapEx$1.2M-1.6%
Free cash flow-$63.5M+0.4%

Valuation

See full
Market cap$1.2B+69.1%
Enterprise value$1.11B+67.9%
P/S429.4×+416×

Profitability

See full
Operating margin-11,365.2%-11,754pp
Net margin-10,994.7%-11,355pp
FCF margin-9,726.7%-10,132pp

Returns & leverage

See full
Return on equity-148.7%-13,871pp
Debt / equity0.1×0.0×
Current ratio4.5×-3.5×

Where this comes from

Reported directly by EyePoint, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AssetsCurrent.

The source filing: EyePoint, Inc.’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:05 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-335037
Line itemJune 30, 2026December 31, 2025
Accounts and other receivables, net86651
Prepaid expenses and other current assets6,37720,105
Inventory1,8821,813
Total current assets188,817328,655
Property and equipment, net10,0139,023
Operating lease right-of-use assets19,84320,223
Restricted cash150150
Other assets9,3685,945

Item 1. Unaudited Financial Statements

FAQ

What is EyePoint, Inc.'s total current assets?
EyePoint, Inc. (EYPT) reported total current assets of $188.82M in Q2 2026.
How has EyePoint, Inc.'s total current assets changed year-over-year?
EyePoint, Inc.'s total current assets decreased by 28.8% year-over-year, from $265.25M to $188.82M.
What is the long-term trend for EyePoint, Inc.'s total current assets?
Over 5 years (2020 to 2025), EyePoint, Inc.'s total current assets has grown at a 39.1% compound annual growth rate (CAGR), from $63.12M to $328.66M.
What does total current assets mean?
The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.

Ask your AI about EyePoint, Inc.'s total current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude